Methyltetrahydro-beta-carbolines and Parkinson's disease. (Q48486108)

11 February 2018

title

Methyltetrahydro-beta-carbolines and Parkinson's disease. (English)

1 reference

11 February 2018

author name string

S Ohkubo

series ordinal

1

1 reference

11 February 2018

T Hiraro

series ordinal

2

1 reference

11 February 2018

K Oka

series ordinal

3

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 June 1985

1 reference

11 February 2018

published in

The Lancet

1 reference

11 February 2018

volume

1

1 reference

11 February 2018

issue

8440

1 reference

11 February 2018

page(s)

1272-1273

1 reference

11 February 2018

Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992338-4

7 January 2021

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992338-4

7 January 2021

Pargyline Prevents MPTP-Induced Parkinsonism in Primates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992338-4

7 January 2021

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992338-4

7 January 2021

Brain enzyme is the target of drug toxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992338-4

7 January 2021

6-Hydroxy-tetrahydronorharmane (6-hydroxy-tetrahydro-?-carboline), a new active metabolite of indole-alkylamines in man and rat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992338-4

7 January 2021

Tryptoline Formation by a Preparation from Brain with 5-Methyltetrahydrofolic Acid and Tryptamine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992338-4

7 January 2021

Monoamine oxidase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992338-4

7 January 2021

Benzodiazepine antagonism by harmane and other β-carbolines in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992338-4

7 January 2021

Actions of tetrahydronorharmane (tetrahydro-beta-carboline) on 5-hydroxytryptamine and dopamine mediated mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992338-4

7 January 2021

10.1016/S0140-6736(85)92338-4

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

2860467

1 reference

11 February 2018